| | | | | |
ANIK Anika Therapeutics Inc | €18,3162 | -1,02 % | €252,93M | €24,35K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | €9,0045 | +0,15 % | €252,85M | €936,82 | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | €8,5919 | -0,25 % | €252,81M | €349,16 | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | €36,9369 | -0,24 % | €252,68M | €4,36K | |
| €38,1894 | -1,41 % | €252,53M | €4,29K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | €8,5962 | +0,20 % | €252,52M | €5,147 | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | €8,6468 | -0,01 % | €252,51M | €272,81 | |
SLN Silence Therapeutics Plc American Depository Share | €11,7712 | -2,69 % | €252,45M | €222,97K | |
MTNE CH4 Natural Solutions Corporation | €8,4718 | +0,04 % | €252,12M | €133,83 | |
RXST RxSight, Inc. Common Stock | €5,4605 | -0,08 % | €251,92M | €130,79K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | €9,1246 | -0,13 % | €251,81M | €45,65K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | €8,5876 | +0,05 % | €251,78M | €48,35K | |
CNXU Conexeu Sciences Inc. Common Stock | €7,4749 | -12,80 % | €251,59M | €176,32K | |
| €8,7763 | +2,40 % | €251,34M | €379,79K | |
JCE Nuveen Core Equity Alpha Fund | €14,7173 | +0,44 % | €251,18M | €5,07K | |
